Skip to main content
SpringerLink
Log in

Treatment of Necrotizing Enterocolitis (NEC) with Amniotic Fluid Stem Cells

  • Chapter
  • First Online:
Perinatal Stem Cells

  • 970 Accesses

Abstract

Necrotizing enterocolitis (NEC) is a devastating disease of newborn infants, characterized by necrosis of one or more portions of the small and/or large bowel.

Despite extensive research and advancement in medical and surgical treatment over the last six decades, NEC still represents a challenging condition with a mortality rate as high as 40 % especially in very low birth weight infants.

Stem cell therapy has become an option for other intestinal diseases, such as refractory Crohn’s disease, which share some features with NEC.

We first attempted administration of amniotic fluid stem (AFS) cells in a well-established neonatal rat model of NEC. In this study, AFS cells integrated in the bowel wall and improved rat survival and clinical conditions, decreased NEC incidence and macroscopic gut damage, improved intestinal function, decreased bowel inflammation, increased enterocyte proliferation and reduced apoptosis. The beneficial effect was achieved via modulation of stromal cells expressing cyclooxygenase 2 in the lamina propria. Moreover, AFS cells differentially expressed genes of the Wnt/β-catenin pathway, which regulate intestinal epithelial stem cell function and cell migration and growth factors known to maintain gut epithelial integrity and reduce mucosal injury.

The same beneficial effects of the amniotic fluid have been later confirmed by other authors using different experimental models of NEC.

Stem cell therapy may represent a new therapeutic option for children with NEC. Understanding the mechanism of action of AFS cells in experimental NEC may help the development of new cellular or pharmacological therapies for human infants with NEC.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Henry MC, Moss RL. Necrotizing enterocolitis. Annu Rev Med. 2009;60:111–24.

    Article  CAS  PubMed  Google Scholar 

  2. Lin PW, Stoll BJ. Necrotising enterocolitis. Lancet. 2006;368(9543):1271–83.

    Article  PubMed  Google Scholar 

  3. Lin PW, Nasr TR, Stoll BJ. Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention. Semin Perinatol. 2008;32(2):70–82.

    Article  PubMed  Google Scholar 

  4. Leaphart CK, Cavallo J, Gribar SC, et al. A critical role for TLR4 in the pathogenesis of necrotizing enterocolitis by modulating intestinal injury and repair. J Immunol. 2007;179:4808–20.

    Article  CAS  PubMed  Google Scholar 

  5. Sodhi CP, Shi XH, Richardson WM, Grant ZS, Shapiro RA, Prindle Jr T, Branca M, Russo A, Gribar SC, Ma C, Hackam DJ. Toll-like receptor-4 inhibits enterocyte proliferation via impaired beta-catenin signaling in necrotizing enterocolitis. Gastroenterology. 2010;138(1):185–96.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  6. Jilling T, Simon D, Lu J, et al. The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J Immunol. 2006;177:3273–82.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Petrosyan M, Guner YS, Williams M, Grishin A, Ford HR. Current concepts regarding the pathogenesis of necrotizing enterocolitis. Pediatr Surg Int. 2009;25(4):309–18.

    Article  PubMed  Google Scholar 

  8. Bokodi G, Derzbach L, Bányász I, Tulassay T, Vásárhelyi B. Association of interferon gamma T +874A and interleukin 12 p40 promoter CTCTAA/GC polymorphism with the need for respiratory support and perinatal complications in low birthweight neonates. Arch Dis Child Fetal Neonatal Ed. 2007;9(1):F25–9.

    Article  Google Scholar 

  9. Bányász I, Bokodi G, Vásárhelyi B, Treszl A, Derzbach L, Szabó A, Tulassay T, Vannay A. Genetic polymorphisms for vascular endothelial growth factor in perinatal complications. Eur Cytokine Netw. 2006;17(4):266–70.

    PubMed  Google Scholar 

  10. Moonen RM, Paulussen AD, Souren NY, Kessels AG, Rubio-Gozalbo ME, Villamor E. Carbamoyl phosphate synthetase polymorphisms as a risk factor for necrotizing enterocolitis. Pediatr Res. 2007;62(2):188–90.

    Article  CAS  PubMed  Google Scholar 

  11. Epelman M, Daneman A, Navarro OM, Morag I, Moore AM, Kim JH, Faingold R, Taylor G, Gerstle JT. Necrotizing enterocolitis: review of state-of-the-art imaging findings with pathologic correlation. Radiographics. 2007;27(2):285–305.

    Article  PubMed  Google Scholar 

  12. Thompson AM, Bizzarro MJ. Necrotizing enterocolitis in newborns: pathogenesis, prevention and management. Drugs. 2008;68(9):1227–38.

    Article  CAS  PubMed  Google Scholar 

  13. Schnabl KL, Van Aerde JE, Thomson AB, Clandinin MT. Necrotizing enterocolitis: a multifactorial disease with no cure. World J Gastroenterol. 2008;14(14):2142–61.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Chung DH, Ethridge RT, Kim S, Owens-Stovall S, Hernandez A, Kelly DR, Evers BM. Molecular mechanisms contributing to necrotizing enterocolitis. Ann Surg. 2001;233(6):835–42.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  15. Hsueh W, Caplan MS, Qu XW, Tan XD, De Plaen IG, Gonzalez-Crussi F. Neonatal necrotizing enterocolitis: clinical considerations and pathogenetic concepts. Pediatr Dev Pathol. 2003;6(1):6–23.

    Article  PubMed  Google Scholar 

  16. Chan KL, Ng SP, Chan KW, Wo YH, Tam PK. Pathogenesis of neonatal necrotizing enterocolitis: a study of the role of intraluminal pressure, age and bacterial concentration. Pediatr Surg Int. 2003;19(8):573–7.

    Article  CAS  PubMed  Google Scholar 

  17. Barlow B, Santulli TV. Importance of multiple episodes of hypoxia or cold stress on the development of enterocolitis in an animal model. Surgery. 1975;77(5):687–90.

    CAS  PubMed  Google Scholar 

  18. Barlow B, Santulli TV, Heird WC, Pitt J, Blanc WA, Schullinger JN. An experimental study of acute neonatal enterocolitis-the importance of breast milk. J Pediatr Surg. 1974;9(5):587–9.

    Article  CAS  PubMed  Google Scholar 

  19. Grishin AV, Wang J, Potoka DA, Hackam DJ, Upperman JS, Boyle P, Zamora R, Ford HR. Lipopolysaccharide induces cyclooxygenase-2 in intestinal epithelium via a noncanonical p38 MAPK pathway. J Immunol. 2006;176(1):580–8.

    Article  CAS  PubMed  Google Scholar 

  20. Zamora R, Bryan NS, Boyle P, Wong C, Milsom AB, Jaffe R, Feelisch M, Ford HR. Nitrosative stress in an animal model of necrotizing enterocolitis. Free Radic Biol Med. 2005;39(11):1428–37.

    Article  CAS  PubMed  Google Scholar 

  21. Feng J, El-Assal ON, Besner GE. Heparin-binding epidermal growth factor-like growth factor reduces intestinal apoptosis in neonatal rats with necrotizing enterocolitis. J Pediatr Surg. 2006;41(4):742–7. discussion 742-7.

    Article  PubMed  Google Scholar 

  22. Zani A, Cordischi L, Cananzi M, De Coppi P, Smith VV, Eaton S, Pierro A. Assessment of a neonatal rat model of necrotizing enterocolitis. Eur J Pediatr Surg. 2008;18(6):423–6.

    Article  CAS  PubMed  Google Scholar 

  23. Sodhi C, Richardson W, Gribar S, et al. The development of animal models for the study of necrotizing enterocolitis. Dis Model Mech. 2008;1:94–8.

    Article  PubMed Central  PubMed  Google Scholar 

  24. De Plaen IG, Liu SX, Tian R, Neequaye I, May MJ, Han XB, Hsueh W, Jilling T, Lu J, Caplan MS. Inhibition of nuclear factor-kappaB ameliorates bowel injury and prolongs survival in a neonatal rat model of necrotizing enterocolitis. Pediatr Res. 2007;61(6):716–21.

    Article  PubMed  Google Scholar 

  25. Drakos PE, Nagler A, Or R. Case of Crohn’s disease in bone marrow transplantation. Am J Hematol. 1993;43(2):157–8.

    Article  CAS  PubMed  Google Scholar 

  26. Okamoto R, Yajima T, Yamazaki M, Kanai T, Mukai M, Okamoto S, Ikeda Y, Hibi T, Inazawa J, Watanabe M. Damaged epithelia regenerated by bone marrow-derived cells in the human gastrointestinal tract. Nat Med. 2002;8(9):1011–7.

    Article  CAS  PubMed  Google Scholar 

  27. Komori M, Tsuji S, Tsujii M, Murata H, Iijima H, Yasumaru M, Nishida T, Irie T, Kawano S, Hori M. Involvement of bone marrow-derived cells in healing of experimental colitis in rats. Wound Repair Regen. 2005;13(1):109–18.

    Article  PubMed  Google Scholar 

  28. Krause DS, Theise ND, Collector MI, Henegariu O, Hwang S, Gardner R, Neutzel S, Sharkis SJ. Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell. 2001;105(3):369–77.

    Article  CAS  PubMed  Google Scholar 

  29. Brittan M, Chance V, Elia G, Poulsom R, Alison MR, MacDonald TT, Wright NA. A regenerative role for bone marrow following experimental colitis: contribution to neovasculogenesis and myofibroblasts. Gastroenterology. 2005;128(7):1984–95.

    Article  PubMed  Google Scholar 

  30. Khalil PN, Weiler V, Nelson PJ, Khalil MN, Moosmann S, Mutschler WE, Siebeck M, Huss R. Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Gastroenterology. 2007;132(3):944–54.

    Article  PubMed  Google Scholar 

  31. Bamba S, Lee CY, Brittan M, Preston SL, Direkze NC, Poulsom R, Alison MR, Wright NA, Otto WR. Bone marrow transplantation ameliorates pathology in interleukin-10 knockout colitic mice. J Pathol. 2006;209(2):265–73.

    Article  CAS  PubMed  Google Scholar 

  32. Tanaka F, Tominaga K, Ochi M, Tanigawa T, Watanabe T, Fujiwara Y, Ohta K, Oshitani N, Higuchi K, Arakawa T. Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. Life Sci. 2008;83(23–24):771–9.

    Article  CAS  PubMed  Google Scholar 

  33. Hayashi Y, Tsuji S, Tsujii M, Nishida T, Ishii S, Iijima H, Nakamura T, Eguchi H, Miyoshi E, Hayashi N, Kawano S. Topical implantation of mesenchymal stem cells has beneficial effects on healing of experimental colitis in rats. J Pharmacol Exp Ther. 2008;326(2):523–31.

    Article  CAS  PubMed  Google Scholar 

  34. Xu J, Woods CR, Mora AL, Joodi R, Brigham KL, Iyer S, Rojas M. Prevention of endotoxin-induced systemic response by bone marrow-derived mesenchymal stem cells in mice. Am J Physiol Lung Cell Mol Physiol. 2007;293(1):L131–41.

    Article  CAS  PubMed  Google Scholar 

  35. Gupta N, Su X, Popov B, Lee JW, Serikov V, Matthay MA. Intrapulmonary delivery of bone marrow-derived mesenchymal stem cells improves survival and attenuates endotoxin- induced acute lung injury in mice. J Immunol. 2007;179(3):1855–63.

    Article  CAS  PubMed  Google Scholar 

  36. Németh K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, Robey PG, Leelahavanichkul K, Koller BH, Brown JM, Hu X, Jelinek I, Star RA, Mezey E. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009;15(1):42–9.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Gonzalez-Rey E, Anderson P, González MA, Rico L, Büscher D, Delgado M. Human adult stem cells derived from adipose tissue protect against experimental colitis and sepsis. Gut. 2009;58(7):929–39.

    Article  CAS  PubMed  Google Scholar 

  38. Tayman C, Uckan D, Kilic E, Ulus AT, Tonbul A, Murat Hirfanoglu I, Helvacioglu F, Haltas H, Koseoglu B, Tatli MM. Mesenchymal stem cell therapy in necrotizing enterocolitis: a rat study. Pediatr Res. 2011;70(5):489–94.

    Article  PubMed  Google Scholar 

  39. Zani A, Cananzi M, Fascetti-Leon F, Lauriti G, Smith VV, Bollini S, Ghionzoli M, D'Arrigo A, Pozzobon M, Piccoli M, Hicks A, Wells J, Siow B, Sebire NJ, Bishop C, Leon A, Atala A, Lythgoe MF, Pierro A, Eaton S, De Coppi P. Amniotic fluid stem cells improve survival and enhance repair of damaged intestine in necrotising enterocolitis via a COX-2 dependent mechanism. Gut. 2014;63(2):300–9.

    CAS  PubMed  Google Scholar 

  40. Schirbel A, Fiocchi C. Inflammatory bowel disease: established and evolving considerations on its etiopathogenesis and therapy. J Dig Dis. 2010;11(5):266–76.

    Article  PubMed  Google Scholar 

  41. Brown SL, Riehl TE, Walker MR, Geske MJ, Doherty JM, Stenson WF, Stappenbeck TS. Myd88- dependent positioning of Ptgs2-expressing stromal cells maintains colonic epithelial proliferation during injury. J Clin Invest. 2007;117(1):258–69.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Bleich A, Hopf S, Hedrich HJ, van Lith HA, Li F, Balfour Sartor R, Mähler M. Genetic dissection of granulomatous enterocolitis and arthritis in the intramural peptidoglycan-polysaccharide- treated rat model of IBD. Inflamm Bowel Dis. 2009;15(12):1794–802.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  43. Mizoguchi A, Mizoguchi E. Animal models of IBD: linkage to human disease. Curr Opin Pharmacol. 2010;10(5):578–87.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  44. Cananzi M, Atala A, De Coppi P. Stem cells derived from amniotic fluid: new potentials in regenerative medicine. Reprod Biomed Online. 2009;18 Suppl 1:17–27.

    Article  PubMed  Google Scholar 

  45. Cananzi M, De Coppi P. CD117(+) amniotic fluid stem cells: state of the art and future perspectives. Organogenesis. 2012;8(3):77–88.

    Article  PubMed Central  PubMed  Google Scholar 

  46. De Coppi P, Bartsch Jr G, Siddiqui MM, Xu T, Santos CC, Perin L, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol. 2007;25:100–6.

    Article  PubMed  Google Scholar 

  47. Bollini S, Pozzobon M, Nobles M, Riegler J, Dong X, Piccoli M, et al. In vitro and in vivo cardiomyogenic differentiation of amniotic fluid stem cells. Stem Cell Rev. 2011a;7:364–80.

    Google Scholar 

  48. Carraro G, Perin L, Sedrakyan S, Giuliani S, Tiozzo C, Lee J, et al. Human amniotic fluid stem cells can integrate and differentiate into epithelial lung lineages. Stem Cells. 2008;26:2902–11.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  49. Ditadi A, de Coppi P, Picone O, Gautreau L, Smati R, Six E, et al. Human and murine amniotic fluid c-Kit+ Lin- cells display hematopoietic activity. Blood. 2009;113:3953–60.

    Article  CAS  PubMed  Google Scholar 

  50. Piccoli M, Franzin C, Bertin E, Urbani L, Blaauw B, Repele A, et al. Amniotic fluid stem cells restore the muscle cell niche in a HSA-Cre, Smn(F7/F7) mouse model. Stem Cells. 2012;30:1675–84.

    Article  CAS  PubMed  Google Scholar 

  51. Bollini S, Cheung KK, Riegler J, Dong X, Smart N, Ghionzoli M, et al. Amniotic fluid stem cells are cardioprotective following acute myocardial infarction. Stem Cells Dev. 2011;20:1985–94.

    Article  CAS  PubMed  Google Scholar 

  52. Perin L, Sedrakyan S, Giuliani S, Da Sacco S, Carraro G, Shiri L, et al. Protective effect of human amniotic fluid stem cells in an immunodeficient mouse model of acute tubular necrosis. PLoS One. 2010;5:e9357.

    Article  PubMed Central  PubMed  Google Scholar 

  53. Sedrakyan S, Da Sacco S, Milanesi A, Shiri L, Petrosyan A, Varimezova R, et al. Injection of amniotic fluid stem cells delays progression of renal fibrosis. J Am Soc Nephrol. 2012;23:661–73.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  54. Rota C, Imberti B, Pozzobon M, Piccoli M, De Coppi P, Atala A, et al. Human amniotic fluid stem cell preconditioning improves their regenerative potential. Stem Cells Dev. 2012;21:1911–23.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  55. Ghionzoli M, Cananzi M, Zani A, Rossi CA, Leon FF, Pierro A, Eaton S, De Coppi P. Amniotic fluid stem cell migration after intraperitoneal injection in pup rats: implication for therapy. Pediatr Surg Int. 2010;26(1):79–84.

    Article  PubMed  Google Scholar 

  56. Good M, Siggers RH, Sodhi CP, et al. Amniotic fluid inhibits Toll-like receptor 4 signaling in the fetal and neonatal intestinal epithelium. Proc Natl Acad Sci U S A. 2012;109:11330–5.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  57. Ford HR. Mechanism of nitric oxide-mediated intestinal barrier failure: insight into the pathogenesis of necrotizing enterocolitis. J Pediatr Surg. 2006;41(2):294–9.

    Article  PubMed  Google Scholar 

  58. Dempke W, Rie C, Grothey A, Schmoll HJ. Cyclooxygenase-2: a novel target for cancer chemotherapy? J Cancer Res Clin Oncol. 2001;127(7):411–7.

    Article  CAS  PubMed  Google Scholar 

  59. Joseph RR, Yazer E, Hanakawa Y, Stadnyk AW. Prostaglandins and activation of AC/cAMP prevents anoikis in IEC-18. Apoptosis. 2005;1(6):1221–33.

    Article  Google Scholar 

  60. Tessner TG, Muhale F, Riehl TE, et al. Prostaglandin E2 reduces radiation-induced epithelial apoptosis through mechanism involving AKT activation and bax translocation. J Clin Invest. 2004;114:1676–85.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  61. Ajuebor MN, Singh A, Wallace JL. Cyclooxygenase-2-derived prostaglandin D(2) is an early anti- inflammatory signal in experimental colitis. Am J Physiol Gastrointest Liver Physiol. 2000;279(1):G238–44.

    CAS  PubMed  Google Scholar 

  62. Gilroy DW, Colville-Nash PR, Willis D, et al. Inducible cyclooxygenase may have anti-inflammatory properties. Nat Med. 1999;5:698–701.

    Article  CAS  PubMed  Google Scholar 

  63. Bertagnolli MM, Eagle CJ, Zauber AG, Redston M, Solomon SD, Kim K, Tang J, Rosenstein RB, Wittes J, Corle D, Hess TM, Woloj GM, Boisserie F, Anderson WF, Viner JL, Bagheri D, Burn J, Chung DC, Dewar T, Foley TR, Hoffman N, Macrae F, Pruitt RE, Saltzman JR, Salzberg B, Sylwestrowicz T, Gordon GB, Hawk ET, APC Study Investigators. Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med. 2006;355(9):873–84.

    Article  CAS  PubMed  Google Scholar 

  64. Hackam DJ, Upperman JS, Grishin A, Ford HR. Disordered enterocyte signaling and intestinal barrier dysfunction in the pathogenesis of necrotizing enterocolitis. Semin Pediatr Surg. 2005;14(1):49–57.

    Article  PubMed  Google Scholar 

  65. Guthrie SO, Gordon PV, Thomas V, Thorp JA, Peabody J, Clark RH. Necrotizing enterocolitis among neonates in the United States. J Perinatol. 2003;23(4):278–85.

    Article  PubMed  Google Scholar 

  66. Lugo B, Ford HR, Grishin A. Molecular signaling in necrotizing enterocolitis: regulation of intestinal COX-2 expression. J Pediatr Surg. 2007;42(7):1165–71.

    Article  PubMed  Google Scholar 

  67. Khailova L, Mount Patrick SK, Arganbright KM, Halpern MD, Kinouchi T, Dvorak B. Bifidobacterium bifidum reduces apoptosis in the intestinal epithelium in necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol. 2010;299(5):G1118–27.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  68. Ciorba M, Riehl TE, Rao S, et al. Lactobacillus probiotic protects intestinal epithelium from radiation injury in TLR-2/cyclooxygenase-2 dependent manner. Gut. 2012;61:829–38.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  69. Riehl TE, Foster L, Stenson WF. Hyaluronic acid is radioprotective in the intestine through a TLR4 and COX-2 mediated mechanism. Am J Physiol Gastrointest Liver Physiol. 2012;302:G309–16.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  70. Tsatsanis C, Androulidaki A, Venihaki M, Margioris AN. Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell Biol. 2006;38(10):1654–61.

    Article  CAS  PubMed  Google Scholar 

  71. Walker MR, Brown SL, Riehl TE, Stenson WF, Stappenbeck TS. Growth factor regulation of prostaglandin-endoperoxide synthase 2 (Ptgs2) expression in colonic mesenchymal stem cells. J Biol Chem. 2010;285(7):5026–39.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  72. McElroy SJ, Hobbs S, Kallen M, Tejera N, Rosen MJ, Grishin A, Matta P, Schneider C, Upperman J, Ford H, Polk DB, Weitkamp JH. Transactivation of EGFR by LPS induces COX-2 expression in enterocytes. PLoS One. 2012;7(5):e38373.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  73. Coursodon CF, Dvorak B. Epidermal growth factor and necrotizing enterocolitis. Curr Opin Pediatr. 2012;24(2):160–4.

    Article  CAS  PubMed  Google Scholar 

  74. Radulescu A, Zhang HY, Yu X, Olson JK, Darbyshire AK, Chen Y, Besner GE. Heparin-binding epidermal growth factor-like growth factor overexpression in transgenic mice increases resistance to necrotizing enterocolitis. J Pediatr Surg. 2010;45(10):1933–9.

    Article  PubMed Central  PubMed  Google Scholar 

  75. Stenson WF. Preventing necrotising enterocolitis with amniotic fluid stem cells. Gut. 2014;63(2):218–9.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric Surgery, University College London Institute of Child Health, 30 Guilford Street, London, WC1N 1EH, UK

    Augusto Zani M.D., Ph.D., Mara Cananzi M.D., Ph.D. & Simon Eaton Ph.D.

  2. Surgery Unit, University College London Institute of Child Health and Great Ormond Street Hospital, London, UK

    Paolo De Coppi M.D., Ph.D.

Authors
  1. Augusto Zani M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mara Cananzi M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Simon Eaton Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Paolo De Coppi M.D., Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paolo De Coppi M.D., Ph.D. .

Editor information

Editors and Affiliations

  1. Wake Forest Baptist Medical Center, Institute for Regenerative Medicine, Winston-Salem, North Carolina, USA

    Anthony Atala

  2. Wake Forest Baptist Medical Center, Institute for Regenerative Medicine, Winston-Salem, North Carolina, USA

    Sean V. Murphy

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Zani, A., Cananzi, M., Eaton, S., De Coppi, P. (2014). Treatment of Necrotizing Enterocolitis (NEC) with Amniotic Fluid Stem Cells. In: Atala, A., Murphy, S. (eds) Perinatal Stem Cells. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1118-9_3

Download citation

Publish with us

Policies and ethics

Search

Navigation